4//SEC Filing
Hathaway David R 4
Accession 0001209191-13-029683
CIK 0001389072other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 5:47 PM ET
Size
9.3 KB
Accession
0001209191-13-029683
Insider Transaction Report
Form 4
Hathaway David R
Chief Medical Officer
Transactions
- Sale
Common Stock
2013-05-28$95.05/sh−5,934$564,027→ 0 total - Exercise/Conversion
Common Stock
2013-05-28$19.22/sh+4,491$86,317→ 5,934 total - Exercise/Conversion
Stock Option (right to buy)
2013-05-28−4,491→ 3,111 totalExercise: $19.22From: 2012-08-13Exp: 2018-08-13→ Common Stock (4,491 underlying)
Footnotes (3)
- [F1]The purchase price of US$19.22 has been converted from AU$19.95 at the spot rate on the date of the transaction.
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $95.00 to $95.45. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The exercise price of US$19.22 has been converted from AU$19.95 at the spot rate on the date of the transaction.
Documents
Issuer
HeartWare International, Inc.
CIK 0001389072
Entity typeother
Related Parties
1- filerCIK 0001434007
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 5:47 PM ET
- Size
- 9.3 KB